BioAtla, Inc. (BCAB)
OTCMKTS · Delayed Price · Currency is USD
1.300
0.00 (0.00%)
At close: Oct 15, 2026
BioAtla Market Cap
BioAtla has a market cap or net worth of $2.17 million as of October 15, 2026. It is the 47,763rd most valuable company in the world and the 6,427th biggest in the United States. Its market cap has decreased by 95.39% in one year.
Market Cap
2.17M
Enterprise Value
6.48M
Revenue
8.50M
Global Rank
Country Rank
#6,427 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 16, 2020, BioAtla's market cap has decreased from 9.78B to 2.17M, a decrease of -99.98%. That is a compound annual growth rate of -76.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 2.17M | -93.54% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aditxt | 2.89M |
| Bioxytran | 2.61M |
| GPL Holdings | 2.56M |
| Mosaic ImmunoEngineering | 2.41M |
| AccuStem Sciences | 2.37M |
| Abpro Holdings | 2.36M |
| International Stem Cell | 2.24M |
| CASI Pharmaceuticals | 2.16M |